Science Explorer Interactive view Map
Topic · Rheumatology

Bone Tumor Diagnosis and Treatments

Bone Tumor Diagnosis and Treatments is a research topic within Rheumatology. Science Explorer counts 34k research works in it since 1950. 7.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis, treatment, and molecular understanding of various bone tumors and tumor-like conditions in the skeletal system, including chondrosarcoma, chordoma, osteoid osteoma, giant cell tumor, fibrous dysplasia, aneurysmal bone cyst, Ollier disease, Maffucci syndrome, enchondroma, and mesenchymal chondrosarcoma.

  • Chondrosarcoma
  • Chordoma
  • Osteoid Osteoma
  • Giant Cell Tumor
  • Fibrous Dysplasia
  • Aneurysmal Bone Cyst
  • Ollier Disease
  • Maffucci Syndrome
  • Enchondroma
  • Mesenchymal Chondrosarcoma
Research works
34k
fractional, since 1950
In the world top 10%
2.4k
per year above
Top-10% rate
7.0%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+7%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Bone Tumor Diagnosis and Treatments research?

By volume, the United States and India publish the most (923 and 779 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 923 works
  2. 2 India 779 works
  3. 3 China 537 works
  4. 4 Japan 287 works
  5. 5 Türkiye 187 works
  6. 6 Brazil 185 works
  7. 7 Italy 168 works
  8. 8 United Kingdom 147 works
  9. 9 Germany 125 works
  10. 10 France 113 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 26.8%India: 22.6%China: 15.6%Japan: 8.3%6 others listed: 26.8%27%largest
United States923 · 26.8%India779 · 22.6%China537 · 15.6%Japan287 · 8.3%6 others listed924 · 26.8%

Shares of the rows listed above, not of the whole node.

Which institutions lead Bone Tumor Diagnosis and Treatments research?

By volume in 2022–2025, All India Institute of Medical Sciences publishes the most Bone Tumor Diagnosis and Treatments research, followed by Datta Meghe Institute of Higher Education and Research and Peking University.

Who are the leading researchers in Bone Tumor Diagnosis and Treatments?

The most-cited researchers publishing on Bone Tumor Diagnosis and Treatments include Marc Ladanyi and Alexander J. Lazar.

  1. 1 Marc Ladanyi United States 3.1k citations
  2. 2 Alexander J. Lazar United States 2.3k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is Bone Tumor Diagnosis and Treatments research done?

The largest centres of Bone Tumor Diagnosis and Treatments research in 2022–2025 are Beijing (China), New Delhi (India), Istanbul (Türkiye) and Chennai (India). Among places with at least 20 works in it, it is an unusually large share of all research in Wardha and Rabat.

Largest cities, 2022–2025

  1. 1 Beijing China 95 works
  2. 2 New Delhi India 74 works
  3. 3 Istanbul Türkiye 65 works
  4. 4 Chennai India 58 works
  5. 5 Tokyo Japan 56 works
  6. 6 New York United States 53 works
  7. 7 Shanghai China 53 works
  8. 8 Seoul South Korea 47 works
  9. 9 Moscow Russia 46 works
  10. 10 London United Kingdom 46 works

Where it is the local speciality

  1. WardhaIN · 23.4 works19×
  2. RabatMA · 27.2 works8.9×
← less than its size predictsmore →

Location quotient: how much more of its research is in Bone Tumor Diagnosis and Treatments than the world average.

See Bone Tumor Diagnosis and Treatments on the map

Where is the best place to study Bone Tumor Diagnosis and Treatments?

Among universities, judged by research, All India Institute of Medical Sciences Bhubaneswar, All India Institute of Medical Sciences and Mohammed V University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 4.97%fractional works in this node (log) →share in the world top 10% →All India Institute of Medical Sciences Bhubaneswar: 17, 11.4%All India Institute of Medical Sciences: 28, 1.5%Mohammed V University: 19, 0.0%Datta Meghe Institute of Higher Education and Research: 22, 0.0%National and Kapodistrian University of Athens: 8, 19.2%Institute of Medical Sciences: 15, 1.1%Sri Ramachandra Institute of Higher Education and Research: 12, 0.0%Iran University of Medical Sciences: 9, 3.1%Peking University: 20, 9.8%Jawaharlal Nehru Medical College: 9, 3.6%All India Institute …All India Institute …Mohammed V UniversityDatta Meghe Institut…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 All India Institute of Medical Sciences BhubaneswarIndia 58.411.4%27.1×17
2 All India Institute of Medical SciencesIndia 49.31.5%9.7×28 -5.5%
3 Mohammed V UniversityMorocco 44.80.0%10.0×19 +9.5%
4 Datta Meghe Institute of Higher Education and ResearchIndia 42.40.0%19.7×22 -18.9%
5 National and Kapodistrian University of AthensGreece 41.619.2%3.3×8 +33.4%
6 Institute of Medical SciencesIndia 41.51.1%10.0×15 +9.2%
7 Sri Ramachandra Institute of Higher Education and ResearchIndia 40.90.0%14.9×12 +89.2%
8 Iran University of Medical SciencesIran 40.93.1%7.0×9 +226.5%
9 Peking UniversityChina 39.19.8%2.6×20 +10.3%
10 Jawaharlal Nehru Medical CollegeIndia 38.43.6%16.4×9

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Bone Tumor Diagnosis and Treatments research growing?

Output in 2018–2022 was 7% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Bone Tumor Diagnosis and Treatments.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.